Improving epilepsy diagnosis with an automated EEG risk score
EpiScalp: An EEG Analytics Solution to Improve Diagnosis of Epilepsy
['FUNDING_SBIR_2'] · NEUROLOGIC SOLUTIONS, INC. · NIH-11168672
This project will use an automated EEG tool called EpiScalp that produces a 0–1 risk score from 10–20 minutes of scalp EEG to help people with suspected seizures get a clearer epilepsy diagnosis.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEUROLOGIC SOLUTIONS, INC. (nih funded) |
| Locations | 1 site (MCLEAN, UNITED STATES) |
| Trial ID | NIH-11168672 on ClinicalTrials.gov |
What this research studies
EpiScalp is an EEG analytics algorithm that analyzes short routine scalp EEG recordings and outputs a 0–1 risk score for epilepsy. The team will further develop the software to better recognize epileptiform signals and to distinguish them from artifacts that can mimic seizures. They plan to validate the tool using clinical EEG recordings and compare its results to standard visual EEG review by clinicians. The goal is to reduce delays and errors in diagnosis so patients spend less time on incorrect treatments or unnecessary testing.
Who could benefit from this research
Good fit: Ideal candidates are people with unexplained spells or suspected seizures who are undergoing routine scalp EEG recording.
Not a fit: People whose epilepsy diagnosis is already firmly established by other tests, those monitored only with implanted intracranial EEG, or people with conditions that do not produce visible scalp EEG changes may not benefit.
Why it matters
Potential benefit: If successful, EpiScalp could reduce epilepsy misdiagnosis, avoid unnecessary antiseizure medications, and speed patients to appropriate treatment.
How similar studies have performed: Previous automated EEG and machine-learning tools have shown promise at detecting epileptiform activity but have not yet eliminated high misdiagnosis rates, so this work builds on promising but still-imperfect approaches.
Where this research is happening
MCLEAN, UNITED STATES
- NEUROLOGIC SOLUTIONS, INC. — MCLEAN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GOTSHALK, ANDREW — NEUROLOGIC SOLUTIONS, INC.
- Study coordinator: GOTSHALK, ANDREW
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.